BridgeBio Pharma, Inc.
BBIO
$38.34
$0.320.84%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 540.60M | 681.10M | 266.32M | 447.77M | 519.69M |
| Total Receivables | 115.27M | 4.72M | 478.00K | 660.00K | 235.49M |
| Inventory | 3.95M | -- | -- | -- | -- |
| Prepaid Expenses | 32.13M | 31.04M | 28.87M | 28.40M | 28.11M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.23M | 3.83M | 148.91M | 139.41M | 131.00K |
| Total Current Assets | 695.17M | 720.69M | 444.58M | 616.24M | 783.42M |
|
|
|||||
| Total Current Assets | 695.17M | 720.69M | 444.58M | 616.24M | 783.42M |
| Net Property, Plant & Equipment | 13.86M | 12.78M | 15.14M | 17.11M | 19.47M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 27.80M | 23.93M | 24.53M | 25.12M | 25.72M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 16.61M | 18.20M | 20.29M | 18.90M | 20.72M |
| Total Assets | 881.64M | 919.34M | 664.98M | 794.38M | 849.33M |
|
|
|||||
| Total Accounts Payable | 27.53M | 9.62M | 13.36M | 18.13M | 4.73M |
| Total Accrued Expenses | 103.25M | 124.08M | 104.70M | 90.14M | 109.48M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.21M | 4.51M | 4.60M | 4.62M | 4.54M |
| Total Finance Division Other Current Liabilities | 16.12M | 16.20M | 16.56M | 21.48M | 22.73M |
| Total Other Current Liabilities | 16.12M | 16.20M | 16.56M | 21.48M | 22.73M |
| Total Current Liabilities | 152.11M | 154.40M | 139.22M | 134.36M | 141.48M |
|
|
|||||
| Total Current Liabilities | 152.11M | 154.40M | 139.22M | 134.36M | 141.48M |
| Long-Term Debt | 1.85B | 1.72B | 1.72B | 1.72B | 1.72B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.92M | 4.70M | 5.83M | 7.06M | 8.30M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 515.16M | 496.47M | 19.00M | 17.45M | 20.49M |
| Total Liabilities | 2.52B | 2.38B | 1.88B | 1.88B | 1.89B |
|
|
|||||
| Common Stock & APIC | 1.94B | 1.90B | 1.88B | 1.85B | 1.82B |
| Retained Earnings | -3.26B | -3.10B | -2.83B | -2.67B | -2.60B |
| Treasury Stock & Other | -323.28M | -274.99M | -275.00M | -275.00M | -275.00M |
| Total Common Equity | -1.65B | -1.47B | -1.23B | -1.09B | -1.05B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.65B | -1.47B | -1.23B | -1.09B | -1.05B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 9.73M | 10.29M | 11.53M | 10.83M | 12.67M |
| Total Equity | -1.64B | -1.46B | -1.22B | -1.08B | -1.04B |
|
|
|||||